These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 18710916)
1. Potential for hepatitis C virus resistance to nitazoxanide or tizoxanide. Korba BE; Elazar M; Lui P; Rossignol JF; Glenn JS Antimicrob Agents Chemother; 2008 Nov; 52(11):4069-71. PubMed ID: 18710916 [TBL] [Abstract][Full Text] [Related]
2. Mutations in HCV non-structural genes do not contribute to resistance to nitazoxanide in replicon-containing cells. Yon C; Viswanathan P; Rossignol JF; Korba B Antiviral Res; 2011 Sep; 91(3):233-40. PubMed ID: 21703309 [TBL] [Abstract][Full Text] [Related]
3. Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication. Korba BE; Montero AB; Farrar K; Gaye K; Mukerjee S; Ayers MS; Rossignol JF Antiviral Res; 2008 Jan; 77(1):56-63. PubMed ID: 17888524 [TBL] [Abstract][Full Text] [Related]
4. Interferon-alpha and ribavirin resistance of Huh7 cells transfected with HCV subgenomic replicon. Aus dem Siepen M; Oniangue-Ndza C; Wiese M; Ross S; Roggendorf M; Viazov S Virus Res; 2007 Apr; 125(1):109-13. PubMed ID: 17254660 [TBL] [Abstract][Full Text] [Related]
5. Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system. Kato T; Date T; Miyamoto M; Sugiyama M; Tanaka Y; Orito E; Ohno T; Sugihara K; Hasegawa I; Fujiwara K; Ito K; Ozasa A; Mizokami M; Wakita T J Clin Microbiol; 2005 Nov; 43(11):5679-84. PubMed ID: 16272504 [TBL] [Abstract][Full Text] [Related]
6. Sensitivity of a ribavirin resistant mutant of hepatitis C virus to other antiviral drugs. Mihalik KB; Feigelstock DA PLoS One; 2013; 8(9):e74027. PubMed ID: 24040153 [TBL] [Abstract][Full Text] [Related]
7. Effect of alpha interferon on the hepatitis C virus replicon. Guo JT; Bichko VV; Seeger C J Virol; 2001 Sep; 75(18):8516-23. PubMed ID: 11507197 [TBL] [Abstract][Full Text] [Related]
8. Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons. Lanford RE; Guerra B; Lee H; Averett DR; Pfeiffer B; Chavez D; Notvall L; Bigger C J Virol; 2003 Jan; 77(2):1092-104. PubMed ID: 12502825 [TBL] [Abstract][Full Text] [Related]
9. In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122. Ottosen S; Parsley TB; Yang L; Zeh K; van Doorn LJ; van der Veer E; Raney AK; Hodges MR; Patick AK Antimicrob Agents Chemother; 2015 Jan; 59(1):599-608. PubMed ID: 25385103 [TBL] [Abstract][Full Text] [Related]
10. Nitazoxanide Inhibits Human Norovirus Replication and Synergizes with Ribavirin by Activation of Cellular Antiviral Response. Dang W; Xu L; Ma B; Chen S; Yin Y; Chang KO; Peppelenbosch MP; Pan Q Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104275 [TBL] [Abstract][Full Text] [Related]
11. Impact of ribavirin on HCV replicon RNA decline during treatment with interferon-α and the protease inhibitors boceprevir or telaprevir. Hofmann WP; Chung TL; Osbahr C; Susser S; Karey U; Mihm U; Welsch C; Lötsch J; Sarrazin C; Zeuzem S; Herrmann E Antivir Ther; 2011; 16(5):695-704. PubMed ID: 21817191 [TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of Pycnogenol® on hepatitis C virus replication. Ezzikouri S; Nishimura T; Kohara M; Benjelloun S; Kino Y; Inoue K; Matsumori A; Tsukiyama-Kohara K Antiviral Res; 2015 Jan; 113():93-102. PubMed ID: 25446333 [TBL] [Abstract][Full Text] [Related]
13. Combinations of 2'-C-methylcytidine analogues with interferon-alpha2b and triple combination with ribavirin in the hepatitis C virus replicon system. Bassit L; Grier J; Bennett M; Schinazi RF Antivir Chem Chemother; 2008; 19(1):25-31. PubMed ID: 18610555 [TBL] [Abstract][Full Text] [Related]
14. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8. Jia Y; Wei L; Jiang D; Wang J; Cong X; Fei R J Gastroenterol Hepatol; 2007 Aug; 22(8):1278-85. PubMed ID: 17565587 [TBL] [Abstract][Full Text] [Related]
15. Ribavirin enhances the action of interferon-α against hepatitis C virus by promoting the p53 activity through the ERK1/2 pathway. Liu WL; Yang HC; Su WC; Wang CC; Chen HL; Wang HY; Huang WH; Chen DS; Lai MY PLoS One; 2012; 7(9):e43824. PubMed ID: 22962590 [TBL] [Abstract][Full Text] [Related]
16. Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha. Tanabe Y; Sakamoto N; Enomoto N; Kurosaki M; Ueda E; Maekawa S; Yamashiro T; Nakagawa M; Chen CH; Kanazawa N; Kakinuma S; Watanabe M J Infect Dis; 2004 Apr; 189(7):1129-39. PubMed ID: 15031779 [TBL] [Abstract][Full Text] [Related]
17. Resistance analysis and characterization of a thiazole analogue, BP008, as a potent hepatitis C virus NS5A inhibitor. Lin HM; Wang JC; Hu HS; Wu PS; Yang CC; Wu CP; Pu SY; Hsu TA; Jiaang WT; Chao YS; Chern JH; Yeh TK; Yueh A Antimicrob Agents Chemother; 2012 Jan; 56(1):44-53. PubMed ID: 22006008 [TBL] [Abstract][Full Text] [Related]
18. In vitro selected Con1 subgenomic replicons resistant to 2'-C-methyl-cytidine or to R1479 show lack of cross resistance. Le Pogam S; Jiang WR; Leveque V; Rajyaguru S; Ma H; Kang H; Jiang S; Singer M; Ali S; Klumpp K; Smith D; Symons J; Cammack N; Nájera I Virology; 2006 Aug; 351(2):349-59. PubMed ID: 16713611 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of subgenomic hepatitis C virus RNA replication in HeLa cells. Kanda T; Yokosuka O; Mikata R; Zhang KY; Tanaka M; Tada M; Fukai K; Imazeki F; Saisho H Hepatogastroenterology; 2007; 54(73):32-5. PubMed ID: 17419226 [TBL] [Abstract][Full Text] [Related]